Text

Second Generation Patents in Pharmaceutical Innovation

---

This is the much-quoted statement of Dr. Marica Angell, the former editorin-chief of the New England Journal of Medicine. It is a sobering reflection on the operational reality that the development of new medications and improvements to those medications play a crucial role in ensuring continued gains in health and longevity. The need for new medicines is never-ending. To spur the investment needed for the continued research and development (“R&D”) of new medicines, economic incentives are essential prerequisites. These incentives can also be provided by intellectual property protection --particularly patents --government funding, or other administrative policies.

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

615 AHN s

Publisher

Baden-Baden : Nomos Verlagsgesellschaft mbH & Co. KG., 2014

Collation

355 halaman

Language

English

ISBN/ISSN

9783845250861

Classification

615

Content Type

text

Media Type

computer

Carrier Type

online resource

Edition

1

Subject(s)

Law / Commercial

Specific Detail Info

-

Statement of Responsibility

Hyewon Ahn

Other Information

Cataloger

agus

Source

-

Validator

maya

Digital Object Identifier (DOI)

-

Journal Volume

-

Journal Issue

-

Subtitle

-

Parallel Title

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment